Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2008
10/15/2008CN100425275C Medicine for treating hepatitis and its preparing process
10/15/2008CN100425273C Medicine for treating gastric ulcer
10/15/2008CN100425267C Chinese medicine for treating stomach disease and its preparing method
10/15/2008CN100425266C Medicine for treating cholecystolithiasis and preparation process thereof
10/15/2008CN100425263C Gastric medicine and its preparation method
10/15/2008CN100425260C Liver medicinal powder
10/15/2008CN100425235C Enteric omeprazole micropill and its preparing method
10/15/2008CN100425234C Pharmaceutical composition containing anti-ulcerative drug and mucosa-protecting agent for treating gastrosis
10/15/2008CN100425232C Buccale tablet preparation and its making method
10/15/2008CN100425228C Dispersion tablets and its prepn. method
10/15/2008CN100425227C Chinese medicine for relieving exterior syndrome, regulating stomach and eliminatnig dampness and its production
10/15/2008CN100425226C Chinese medicine composition for treating acute cholecystitis and preparing method thereof
10/15/2008CN100425161C A fat-reducing food additive and application thereof
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435756 Preparation and diabetic use of gibberellins
10/14/2008US7435750 Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/14/2008US7435745 Methods and compositions for inhibition of angiogenesis
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435742 potent antagonists of M3 muscarinic receptors; chronic obstructive pulmonary disease; bronchitis, bronchial hyperreactivity, asthma, cough and rhinitis; gastrointestinal disorders; incontinenc; [2-(3,4-Dimethoxyphenyl)ethyl]-(5-methylfuran-2-ylmethyl)carbamic acid (3R)-1 -azabicyclo[2.2.2]oct-3-yl ester
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435725 Oral compositions and methods for prevention, reduction and treatment of radiation injury
10/14/2008US7435724 Degradation-resistant mononucleoside phosphate compounds
10/14/2008CA2497345C Novel quaternary ammonium compounds
10/14/2008CA2338649C New phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions
10/14/2008CA2331395C Fatty acid analogues for the treatment of diabetes
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/12/2008CA2629790A1 Use of avian anti-methanogen antibodies for reduction of methane production
10/09/2008WO2008121386A2 Calcimimetic compounds for use in the treatment of bowel disorders
10/09/2008WO2008121046A1 Improvement of gastric emptying in patients suffering from diabetes mellitus
10/09/2008WO2008120818A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
10/09/2008WO2008120797A1 Ampk activator
10/09/2008WO2008120744A1 Five-membered cyclic amide compound and use thereof
10/09/2008WO2008120720A1 Dentinogenesis promoter and dentinogenic pulp-capping material
10/09/2008WO2008120713A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions
10/09/2008WO2008120712A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity
10/09/2008WO2008120708A1 Engraftment enhancer or proliferation enhancer in tissue plantation
10/09/2008WO2008120653A1 Indoledione derivative
10/09/2008WO2008120617A1 Pharmaceutical composition for prevention of progress of intestinal constriction associated with crohn's disease
10/09/2008WO2008119694A1 Benzimidazole cannabinoid agonists
10/09/2008WO2008119534A1 Production of a viable, storable worm egg suspension
10/09/2008US20080249177 Selective beta 3-adrenoceptor stimulants; obesity, diabetes mellitus, hyperlipidemia, pollakiuria, urinary incontinence, intestinal hypermotility; e.g. 4'-{2-[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl ethylamino]ethoxy}-2,3',5'-trimethylbiphenyl-4-carboxylic acid
10/09/2008US20080249155 5-Hydroxyindole-3-Carboxylate Derivatives and Uses Thereof
10/09/2008US20080249154 Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates
10/09/2008US20080249147 Emulsion-Stabilized Preparation
10/09/2008US20080249133 Use of Substituted 2-Thio-3,5-Dicyano-4-Phenyl-6-Aminopyridines In the Treatment of Nausea and Vomiting
10/09/2008US20080249114 Beta-3 adrenergic receptor agonists; urinary tract infections, incontinence, gastrointestinal disorders, dysmenorrhea, obesity; tocolytic, anxiolytic, antidiabetic agents; antidepressants; 4-(2-hydroxy-3-(1-(5-phenylthieno[2,3-d]pyrimidin-4-yl)piperidin-4-ylamino)propoxy)phenol
10/09/2008US20080249108 treatment of sleep disorders or inflammatory diseases of the bladder by administering N-benzyl-2-phenylpiperazine-1-carboxamides, e.g., 2-(S)-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methyl-amide methansulfonate
10/09/2008US20080249072 Use of Low Dose Chemically Modified Tetracylines to Reduce Inflammatory Mediators
10/09/2008US20080249067 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP)
10/09/2008US20080249048 such as IBD and Crohn's disease; intrarectal administration of siNA compounds
10/09/2008US20080249034 For both the treatment of inflammatory bowel diseases and the prevention of colon cancer; O5-[3-oxoethyl)-methylamino- beta -D-xylo-3,4,6-trideoxy-hexapyranosyl]-9-hydroxy-9-deoxo-erythronolide-A; side effect reduction
10/09/2008US20080249031 Of (3S)-3-[N (N'-(2-tert-butylphenyl)oxamyl)alaninyl]amino-5-(2',3',5',6'-tetrafluorophenoxy)-4-oxopentanoic acid; liver fibrosis
10/09/2008US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions
10/09/2008US20080248566 Matriptase, a serine protease and its applications
10/09/2008US20080248136 Acute and chronic heartburn composition and method
10/09/2008US20080248124 Process for producing pharmaceutical composition
10/09/2008US20080248109 succinic acid particles or any salts and (ii) hydroxypropyl methyl cellulose phthalate an enteric-coated proton pump inhibitor (PPI) omeprazole; succinic acid particles are released in the stomach in an amount sufficient to reduce gastric acid secretion in conjunction with the PPI; sustained release
10/09/2008US20080248029 Prevention and treatment of amyloidogenic diseases
10/09/2008US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein
10/09/2008US20080248018 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders
10/09/2008CA2682727A1 Indoledione derivative
10/09/2008CA2682613A1 Oral care compositions containing a mixed tocopherol component
10/09/2008CA2682525A1 Production of a viable, storable worm egg suspension
10/09/2008CA2682375A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous activity
10/09/2008CA2682374A1 Medicinal composition, food or drink having effect of enhancing sympathetic nervous activity
10/09/2008CA2681979A1 Indole derivatives having cpla2 inhibiting activity and applications and production methods of the same
10/09/2008CA2681582A1 Methods of treating bowel disorders
10/08/2008EP1978034A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same
10/08/2008EP1977753A1 Combined preparation comprising anthracycline derivatives
10/08/2008EP1977751A1 Use of crystalline (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole for manufacturing pharmaceutical compositions
10/08/2008EP1977643A1 Manufacture of a viable, storable worm egg suspension
10/08/2008EP1977249A2 Method of diagnosis and method of treatment
10/08/2008EP1976532A2 Fast acting inhibitor of gastric acid secretion
10/08/2008EP1976528A2 Prokineticin 2 receptor antagonists
10/08/2008EP1976520A2 Kit comprising an osmotic laxative and a stimulant laxative for preparing the colon for virtual colonoscopy
10/08/2008EP1976508A2 Flavonoids isolated from oroxylum indicum for treatment of gastrointestinal toxicity, associated symptoms and ulcers
10/08/2008EP1976501A1 Compositions and methods for preventing or treating inflammatory bowel disease
10/08/2008EP1646390B1 A1 adenosine receptor antagonists
10/08/2008EP1539693B9 Cannabinoid receptor agonists
10/08/2008EP1485390B1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
10/08/2008EP1464331B1 Compressed oral pharmaceutical dosage form, with an enteric coating, which contains an acid-labile benzimidazole compound
10/08/2008EP1455761B1 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
10/08/2008EP1141334B1 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
10/08/2008EP1043995B9 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008CN201127787Y Externally used medicament tube for curing icterohepatitis
10/08/2008CN101280261A Health wine
10/08/2008CN101280258A Cosmetic nutritious health care yellow wine and preparation thereof
10/08/2008CN101279091A Pancreatic enzymes enteric coated pellets and preparation
10/08/2008CN101279086A Chinese medicine for curing gastroptosis
10/08/2008CN101279083A Chinese medicine preparation for curing acute or chronic cholecystitis and method of preparing the same
10/08/2008CN101279078A Chinese medicinal composition for treating gastropathy and method of preparing the same
10/08/2008CN101279072A Chinese medicine capsule for curing digestive system disease
10/08/2008CN101279055A Novel therapeutic use of ginseng and astragali pollen preparations and quality control method
10/08/2008CN101279046A Chinese medicinal composition for curing labyrinthine syndrome
10/08/2008CN101279041A Chinese medicinal composition for curing ulcer of upper digestive tract
10/08/2008CN101279039A Chinese medicinal enema for curing colonitis and method of preparing the same
10/08/2008CN101279037A Composition for curing impairment by overeating, preparation and quality control method
10/08/2008CN101279024A Chinese medicinal composition for treating anal fistula and method of preparing the same
10/08/2008CN101279022A Preparation of Simotang enema and suppositorium
1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 1258